OMNIAB, INC. Payment for Contingent Consideration Liability, Investing Activities
OMNIAB, INC. (OABI) reported Payment for Contingent Consideration Liability, Investing Activities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities · last filed 2026-03-04
- OMNIAB, INC. payment for contingent consideration liability, investing activities for the quarter ending 2025-12-31 was $0.00.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for the quarter ending 2025-09-30 was $0.00.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for the quarter ending 2025-06-30 was $0.00.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for fiscal 2024 was $400.00K, a 90.99% decline from fiscal 2023.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for fiscal 2023 was $4.44M, a 208.33% increase from fiscal 2022.
- OMNIAB, INC. payment for contingent consideration liability, investing activities for fiscal 2022 was $1.44M, a 100.00% increase from fiscal 2021.
| Period end | Payment for Contingent Consideration Liability, Investing Activities 3 month | Payment for Contingent Consideration Liability, Investing Activities 6 month | Payment for Contingent Consideration Liability, Investing Activities 9 month | Payment for Contingent Consideration Liability, Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $0.00 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $0.00 derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $0.00 derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $400.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $400.00K 10-Q · filed 2025-11-04 | $1.20M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $400.00K 10-Q · filed 2025-08-06 | $1.20M derived: sum of 3 quarters · filed 2025-08-06 | $2.04M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-08 | $1.20M derived: sum of 2 quarters · filed 2025-05-08 | $2.04M derived: sum of 3 quarters · filed 2025-05-08 | $2.76M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.64M derived: sum of 2 quarters · filed 2025-03-18 | $2.36M derived: sum of 3 quarters · filed 2025-03-18 | $4.44M 10-K · filed 2025-03-18 |
| 2023-09-30 | $840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.56M derived: sum of 2 quarters · filed 2024-11-12 | $3.64M 10-Q · filed 2024-11-12 | $4.12M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $720.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.80M 10-Q · filed 2024-08-08 | $3.28M derived: sum of 3 quarters · filed 2024-08-08 | $4.24M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-09 | $2.56M derived: sum of 2 quarters · filed 2024-05-09 | $3.52M derived: sum of 3 quarters · filed 2024-05-09 | $3.52M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.44M derived: sum of 2 quarters · filed 2024-03-25 | $1.44M derived: sum of 3 quarters · filed 2024-03-25 | $1.44M 10-K · filed 2024-03-25 |
| 2022-09-30 | $960.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $960.00K derived: sum of 2 quarters · filed 2023-11-09 | $960.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $720.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |